Literature DB >> 33340663

Discovery of a series of 1H-pyrrolo[2,3-b]pyridine compounds as potent TNIK inhibitors.

Bowen Yang1, Qian Wu2, Xiajuan Huan2, Yingqing Wang2, Yin Sun3, Yueyue Yang4, Tongchao Liu4, Xin Wang4, Lin Chen4, Bing Xiong4, Dongmei Zhao5, Zehong Miao6, Danqi Chen7.   

Abstract

In an in-house screening, 1H-pyrrolo[2,3-b]pyridine scaffold was found to have high inhibition on TNIK. Several series of compounds were designed and synthesized, among which some compounds had potent TNIK inhibition with IC50 values lower than 1 nM. Some compounds showed concentration-dependent characteristics of IL-2 inhibition. These results provided new applications of TNIK inhibitors and new prospects of TNIK as a drug target.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1H-pyrrolo[2,3-b]pyridine; IL-2 secretion inhibitory; TNIK inhibitor

Year:  2020        PMID: 33340663     DOI: 10.1016/j.bmcl.2020.127749

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  TNKS inhibitors potentiate proliferative inhibition of BET inhibitors via reducing β-Catenin in colorectal cancer cells.

Authors:  Qian Wu; Yi-Fei Xuan; Ai-Ling Su; Xu-Bin Bao; Ze-Hong Miao; Ying-Qing Wang
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.